NM_000251.3:c.1007delC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000251.3(MSH2):c.1007delC(p.Pro336LeufsTer21) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000251.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Lynch syndrome Pathogenic:1
Coding sequence variant introducing a premature termination codon -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1007delC variant, located in coding exon 6 of the MSH2 gene, results from a deletion of one nucleotide at nucleotide position 1007, causing a translational frameshift with a predicted alternate stop codon (p.P336Lfs*21). In a study of 1721 German probands suspected of HNPCC, this mutation (designated as c.1005_1008delCCCC) was detected in 1 family (Mangold E et al. Int J Cancer. 2005 Sep 20;116(5):692-702). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at